Systematic reviewindependent cross-checkabstract checked★ key study I-SUG-104 in-depth review
Large 2026 overview: sugar linked to many diseases
The oral und systemic health risks of sugar consumption: an umbrella review.
Overview
Woelber JP et al.. Clin Oral Investig 2026 · PMID 42814269 · DOI 10.1007/s00784-026-07191-1
A 2026 review of 228 systematic reviews found sugar intake consistently linked with 18 harmful health outcomes, mostly from sugary-drink studies.
Does the study support the specific claim? No · Methodological quality: moderate
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Summarise what systematic reviews say about sugar and health.
- How was the study done?
Searched three databases up to March 2026 and rated the quality of each review.
- How many people, animals or samples were studied?
228 systematic reviews.
- What was actually found?
Sugar intake was linked to diabetes, obesity, heart disease, death, dental disease and more.
- How large was the observed effect?
Narrative; no pooled numbers.
- What do the results mean in everyday life?
Supports limiting free sugars.
- What are the study's limitations?
Many included reviews were of low quality; overlapping data.
- What does it say about Elawady's specific claim?
Contradicts the idea that any amount of sugar is good.
- Do the results apply to Germany and Europe?
International evidence, applicable to Europe and Egypt.
- What can explicitly not be concluded from this study?
Cannot give exact safe amounts or prove causation for every outcome.
Scientific in-depth review
1. Full reference
- Authors
- Woelber JP et al.
- Journal
- Clin Oral Investig
- Year
- 2026
- Identifier
- PMID 42814269 DOI 10.1007/s00784-026-07191-1
- Verification
- verified – PubMed efetch 2026-10-26 + Crossref 2026-10-26
- Retracted
- no
- Corrections
- none
- Extent checked
- abstract only
- Conflicts of interest and funding
Authors declare no competing interests (PubMed record)
2. Research question
Which oral and general health outcomes are associated with free sugar consumption?
3. Study design and population
- Study design
- Systematic review – Umbrella review of systematic reviews (Epistemonikos, PubMed, Cochrane; to March 2026), AMSTAR-2, narrative synthesis; PROSPERO CRD42023380458
- Population
Systematic reviews of human studies
- Country
International
- Period
Searched up to March 2026
- Sample size
228 systematic reviews
- Inclusion and exclusion criteria
Systematic reviews of free sugar consumption alone or as part of dietary patterns
4. Methods and endpoints
- Exposure / intervention
Free sugar intake (68% of studies: sugar-sweetened beverages)
- Comparator
Lower intake
- Endpoints
18 health outcomes including type 2 diabetes, obesity, cardiovascular and all-cause mortality, oral disease
- Statistical methods
Narrative synthesis; AMSTAR-2 quality rating
5. Actual results
- Results
Sugar intake was consistently associated with increased risk of 18 negative health outcomes; strongest evidence for type 2 diabetes, obesity, cardiovascular and all-cause mortality, oral diseases, irritable bowel syndrome and cognitive disorders. Most included reviews had low or critically low AMSTAR-2 quality; about one third moderate to high. 68% of studies examined sugar-sweetened beverages.
- Absolute risks
not reported
- Authors' conclusion
Avoiding free sugar contributes to reduced chronic disease burden and improved oral health.
6. Strengths
- Most recent and broad overview (to March 2026)
- Registered protocol
- Two independent reviewers
7. Weaknesses
- Narrative synthesis without pooled estimates
- Most included reviews low quality
- Overlap of primary studies not quantified in abstract
- Dominated by SSB evidence
8. Risk of bias
- Orienting tool
- ROBIS
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- some concerns
- Rationale
Breadth over depth; quality of underlying reviews mostly low.
9. Assessment of the statistical interpretation
Counts of associations across overlapping reviews are not independent confirmations; the direction is consistent but the strength per outcome must be taken from higher-quality reviews (I-SUG-02, I-SUG-03).
10. Relevance to the specific claim
Newest evidence overview contradicting the claim that any amount of sugar is beneficial.
11. Independent contrary findings
I-SUG-103 and I-SUG-105 show that sugar from foods at moderate intakes is not consistently associated with harm.
12. Transferability to Germany and Europe
International; applicable.
13. Overall methodological judgement
Confirms the direction of the earlier umbrella review (I-SUG-02); adds recency, not independent new data.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | moderate |
| Risk of bias | some concerns |
| Precision of results | not applicable |
| Directness | direct |
| Reproducibility | replicated |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
Dose thresholds and source dependence.
15. Linked fact checks
- White sugar is the greatest product humans ever made; any amount of sugar per day is beneficial, and one can eat a kilogram of white sugar or honey. – Studies contradicting or limiting the claim